EBIT: Income before interest and taxes.
Acurx Pharmaceuticals, Inc. (ACXP) had EBIT of $-2.15M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-2.15M |
|
-- |
|
-- |
|
$2.15M |
|
$-2.15M |
|
-- |
|
$-2.15M |
|
$-2.15M |
|
$-2.15M |
|
$-2.15M |
|
$-2.15M |
|
$-2.15M |
|
|
EBIT |
$-2.15M |
$-2.15M |
|
20.04M |
|
20.04M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$4.81M |
|
-- |
|
-- |
|
$4.81M |
|
$2.49M |
|
-- |
|
-- |
|
$2.49M |
|
$2.31M |
|
$2.31M |
|
$2.31M |
|
22.40M |
|
| Cash Flow Statement Financials | |
$-2.05M |
|
-- |
|
$2.99M |
|
$3.71M |
|
$4.64M |
|
$0.94M |
|
$0.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.93 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-92.98% |
|
-92.98% |
|
-44.72% |
|
-92.98% |
|
$0.10 |
|
$-0.10 |
|
$-0.10 |
|